Literature DB >> 20007707

The protein-protein interface evolution acts in a similar way to antibody affinity maturation.

Bohua Li1, Lei Zhao2, Chong Wang3, Huaizu Guo3, Lan Wu2, Xunming Zhang2, Weizhu Qian1, Hao Wang1, Yajun Guo4.   

Abstract

Understanding the evolutionary mechanism that acts at the interfaces of protein-protein complexes is a fundamental issue with high interest for delineating the macromolecular complexes and networks responsible for regulation and complexity in biological systems. To investigate whether the evolution of protein-protein interface acts in a similar way as antibody affinity maturation, we incorporated evolutionary information derived from antibody affinity maturation with common simulation techniques to evaluate prediction success rates of the computational method in affinity improvement in four different systems: antibody-receptor, antibody-peptide, receptor-membrane ligand, and receptor-soluble ligand. It was interesting to find that the same evolutionary information could improve the prediction success rates in all the four protein-protein complexes with an exceptional high accuracy (>57%). One of the most striking findings in our present study is that not only in the antibody-combining site but in other protein-protein interfaces almost all of the affinity-enhancing mutations are located at the germline hotspot sequences (RGYW or WA), indicating that DNA hot spot mechanisms may be widely used in the evolution of protein-protein interfaces. Our data suggest that the evolution of distinct protein-protein interfaces may use the same basic strategy under selection pressure to maintain interactions. Additionally, our data indicate that classical simulation techniques incorporating the evolutionary information derived from in vivo antibody affinity maturation can be utilized as a powerful tool to improve the binding affinity of protein-protein complex with a high accuracy.

Mesh:

Substances:

Year:  2009        PMID: 20007707      PMCID: PMC2823529          DOI: 10.1074/jbc.M109.076547

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Towards an understanding of somatic hypermutation.

Authors:  H Jacobs; L Bross
Journal:  Curr Opin Immunol       Date:  2001-04       Impact factor: 7.486

2.  Somatic mutation hotspots correlate with DNA polymerase eta error spectrum.

Authors:  I B Rogozin; Y I Pavlov; K Bebenek; T Matsuda; T A Kunkel
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

3.  X-ray snapshots of the maturation of an antibody response to a protein antigen.

Authors:  Yili Li; Hongmin Li; Feng Yang; Sandra J Smith-Gill; Roy A Mariuzza
Journal:  Nat Struct Biol       Date:  2003-06

4.  Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design.

Authors:  Louis A Clark; P Ann Boriack-Sjodin; John Eldredge; Christopher Fitch; Bethany Friedman; Karl J M Hanf; Matthew Jarpe; Stefano F Liparoto; You Li; Alexey Lugovskoy; Stephan Miller; Mia Rushe; Woody Sherman; Kenneth Simon; Herman Van Vlijmen
Journal:  Protein Sci       Date:  2006-04-05       Impact factor: 6.725

5.  Structure-based protocol for identifying mutations that enhance protein-protein binding affinities.

Authors:  Deanne W Sammond; Ziad M Eletr; Carrie Purbeck; Randall J Kimple; David P Siderovski; Brian Kuhlman
Journal:  J Mol Biol       Date:  2007-06-08       Impact factor: 5.469

6.  The imprint of somatic hypermutation on the repertoire of human germline V genes.

Authors:  I M Tomlinson; G Walter; P T Jones; P H Dear; E L Sonnhammer; G Winter
Journal:  J Mol Biol       Date:  1996-03-15       Impact factor: 5.469

7.  Rational design of intercellular adhesion molecule-1 (ICAM-1) variants for antagonizing integrin lymphocyte function-associated antigen-1-dependent adhesion.

Authors:  Gang Song; Greg A Lazar; Tanja Kortemme; Motomu Shimaoka; John R Desjarlais; David Baker; Timothy A Springer
Journal:  J Biol Chem       Date:  2005-12-14       Impact factor: 5.157

8.  Validation and use of the MM-PBSA approach for drug discovery.

Authors:  Bernd Kuhn; Paul Gerber; Tanja Schulz-Gasch; Martin Stahl
Journal:  J Med Chem       Date:  2005-06-16       Impact factor: 7.446

Review 9.  Interactions of protein antigens with antibodies.

Authors:  D R Davies; G H Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

10.  Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition.

Authors:  Frederic A Fellouse; Christian Wiesmann; Sachdev S Sidhu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

View more
  6 in total

1.  Combating HER2-overexpressing breast cancer through induction of calreticulin exposure by Tras-Permut CrossMab.

Authors:  Fan Zhang; Jie Zhang; Moyan Liu; Lichao Zhao; RuiXia LingHu; Fan Feng; Xudong Gao; Shunchang Jiao; Lei Zhao; Yi Hu; Junlan Yang
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

2.  IsAb: a computational protocol for antibody design.

Authors:  Tianjian Liang; Hui Chen; Jiayi Yuan; Chen Jiang; Yixuan Hao; Yuanqiang Wang; Zhiwei Feng; Xiang-Qun Xie
Journal:  Brief Bioinform       Date:  2021-09-02       Impact factor: 11.622

3.  T-Cell Receptor Variable β Domains Rigidify During Affinity Maturation.

Authors:  Monica L Fernández-Quintero; Clarissa A Seidler; Klaus R Liedl
Journal:  Sci Rep       Date:  2020-03-11       Impact factor: 4.379

4.  Structure-based design and discovery of novel anti-tissue factor antibodies with cooperative double-point mutations, using interaction analysis.

Authors:  Shuntaro Chiba; Aki Tanabe; Makoto Nakakido; Yasushi Okuno; Kouhei Tsumoto; Masateru Ohta
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

5.  Surprisingly Fast Interface and Elbow Angle Dynamics of Antigen-Binding Fragments.

Authors:  Monica L Fernández-Quintero; Katharina B Kroell; Martin C Heiss; Johannes R Loeffler; Patrick K Quoika; Franz Waibl; Alexander Bujotzek; Ekkehard Moessner; Guy Georges; Klaus R Liedl
Journal:  Front Mol Biosci       Date:  2020-11-24

6.  Gastric DLBCL clonal evolution as function of patient age.

Authors:  Irina Iosselevitch; Hilla Tabibian-Keissar; Iris Barshack; Ramit Mehr
Journal:  Front Immunol       Date:  2022-08-29       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.